VALID Act Sample Letter to Congress
Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.
VALID Act
AdvaMedDx® Media Message Points on the VALID Act
AdvaMedDx® has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMedDx® Letter to VALID Sponsors
AdvaMedDx® wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.
AdvaMed®: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests
AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Diagnostics Regulatory Reform
AdvaMedDx® supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all…
AdvaMed® Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
AdvaMed® Statement on HHS Rescission of Policies on Laboratory Developed Tests During COVID and Beyond
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:
AdvaMedDx® VALID Assessment Framework
AdvaMedDx® developed the VALID Assessment Framework as a tool to analyze the legislation.
VALID Act 2020 Comprehensive Summary
The VALID Act seeks to modernize FDA oversight of in vitro diagnostics.
AdvaMedDx® VALID Act Webinar, March 20, 2020 – Presentation
On March 5, 2020, the VALID Act was introduced in the Senate and House.